TLE3 was shown to co-localize with FOXA1 and AR at enhancer elements, which are selectively activated during prostate tumorigenesis (Stelloo et al., 2018), underscoring the importance of these transcription factors in this context. This evidence concerns the gene TLE3 and prostatitis.